The influence of alpha-receptors on lordosis in the female rat

Lab / animal OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-17 ⓘ

The alpha-adrenergic agonist clonidine suppressed lordosis in female rats, an effect blocked by yohimbine, suggesting distinct alpha-adrenergic receptor roles in the brain.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The alpha-adrenergic agonist clonidine suppressed lordotic responding in spayed female rats brought into heat by estrogen and progesterone. The suppression was blocked by the alpha-antagonist yohimbine, but not by phenoxybenzamine or pimozide. The suppression was blocked by the alpha-antagonist yohimbine, but not by phenoxybenzamine or pimozide. Phenoxybenzamine itself had no suppressive effect on lordosis, though yohimbine did under some conditions. These results argue against an important facilitatory influence of norepinephrine on lordosis in the rat. Further, in comparison with the quite different findings recently reported from the guinea pig, they offer support for the presence of two different kinds of alpha-adrenergic receptors in the brain with different physiological functions.

My notes (saved in your browser only)

MeSH descriptors

Receptors, Adrenergic Receptors, Adrenergic, alpha Sexual Behavior, Animal Animals Castration Clonidine Clonidine Drug Interactions Female Phenoxybenzamine Phenoxybenzamine Pimozide Pimozide Rats Receptors, Adrenergic Receptors, Adrenergic, alpha Receptors, Adrenergic, alpha Sexual Behavior, Animal Sexual Behavior, Animal Yohimbine

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (3)

References (45)

Cited by (3)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:06:07.402396+00:00
unpaywall
last seen: 2026-11-08T06:46:05.892536+00:00
License: CC0 · commercial use OK